These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889 [TBL] [Abstract][Full Text] [Related]
4. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response. Law M; Oh S; Babb JS; Wang E; Inglese M; Zagzag D; Knopp EA; Johnson G Radiology; 2006 Feb; 238(2):658-67. PubMed ID: 16396838 [TBL] [Abstract][Full Text] [Related]
5. Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade. Kang Y; Choi SH; Kim YJ; Kim KG; Sohn CH; Kim JH; Yun TJ; Chang KH Radiology; 2011 Dec; 261(3):882-90. PubMed ID: 21969667 [TBL] [Abstract][Full Text] [Related]
6. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868 [TBL] [Abstract][Full Text] [Related]
7. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. Shin JH; Lee HK; Kwun BD; Kim JS; Kang W; Choi CG; Suh DC AJR Am J Roentgenol; 2002 Sep; 179(3):783-9. PubMed ID: 12185064 [TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Rollin N; Guyotat J; Streichenberger N; Honnorat J; Tran Minh VA; Cotton F Neuroradiology; 2006 Mar; 48(3):150-9. PubMed ID: 16470375 [TBL] [Abstract][Full Text] [Related]
9. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema. Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234 [TBL] [Abstract][Full Text] [Related]
10. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. Sugahara T; Korogi Y; Kochi M; Ikushima I; Hirai T; Okuda T; Shigematsu Y; Liang L; Ge Y; Ushio Y; Takahashi M AJR Am J Roentgenol; 1998 Dec; 171(6):1479-86. PubMed ID: 9843274 [TBL] [Abstract][Full Text] [Related]
11. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Emblem KE; Nedregaard B; Nome T; Due-Tonnessen P; Hald JK; Scheie D; Borota OC; Cvancarova M; Bjornerud A Radiology; 2008 Jun; 247(3):808-17. PubMed ID: 18487536 [TBL] [Abstract][Full Text] [Related]
13. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107 [TBL] [Abstract][Full Text] [Related]
14. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas. Thomsen H; Steffensen E; Larsson EM Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021 [TBL] [Abstract][Full Text] [Related]
15. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging. Arvinda HR; Kesavadas C; Sarma PS; Thomas B; Radhakrishnan VV; Gupta AK; Kapilamoorthy TR; Nair S J Neurooncol; 2009 Aug; 94(1):87-96. PubMed ID: 19229590 [TBL] [Abstract][Full Text] [Related]
16. Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Stadlbauer A; Ganslandt O; Buslei R; Hammen T; Gruber S; Moser E; Buchfelder M; Salomonowitz E; Nimsky C Radiology; 2006 Sep; 240(3):803-10. PubMed ID: 16926329 [TBL] [Abstract][Full Text] [Related]
17. Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article. Yordanova YN; Moritz-Gasser S; Duffau H J Neurosurg; 2011 Aug; 115(2):232-9. PubMed ID: 21548750 [TBL] [Abstract][Full Text] [Related]
18. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790 [TBL] [Abstract][Full Text] [Related]
19. Low-grade and anaplastic gliomas: differences in architecture evaluated with diffusion-tensor MR imaging. Goebell E; Paustenbach S; Vaeterlein O; Ding XQ; Heese O; Fiehler J; Kucinski T; Hagel C; Westphal M; Zeumer H Radiology; 2006 Apr; 239(1):217-22. PubMed ID: 16484348 [TBL] [Abstract][Full Text] [Related]
20. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Law M; Young RJ; Babb JS; Peccerelli N; Chheang S; Gruber ML; Miller DC; Golfinos JG; Zagzag D; Johnson G Radiology; 2008 May; 247(2):490-8. PubMed ID: 18349315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]